Wolff Wiese Magana LLC Vertex Pharmaceuticals Inc Transaction History

Wolff Wiese Magana LLC

$146 Million
Q4 2024

A detailed history of Wolff Wiese Magana LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 151 shares of VRTX stock, worth $66,382. This represents 0.04% of its overall portfolio holdings.

Number of Shares

151

Previous 156 3.21%

Holding current value

$66,382

Previous $72,000 16.67%

% of portfolio

0.04%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$396.64 - $516.74 $1,983 - $2,583	-5 Reduced 3.21%	151 $60,000
Q3 2024 Oct 16, 2024	BUY	$460.0 - $505.78 $51,520 - $56,647	112 Added 254.55%	156 $72,000
Q2 2024 Jul 12, 2024	SELL	$392.81 - $485.53 $9,820 - $12,138	-25 Reduced 36.23%	44 $20,000
Q1 2024 Apr 18, 2024	SELL	$407.69 - $446.08 $6,115 - $6,691	-15 Reduced 17.86%	69 $28,000
Q4 2023 Jan 16, 2024	SELL	$343.0 - $410.68 $1,715 - $2,053	-5 Reduced 5.62%	84 $34,000
Q3 2023 Oct 30, 2023	SELL	$338.18 - $362.46 $676 - $724	-2 Reduced 2.2%	89 $30,000
Q2 2023 Aug 01, 2023	SELL	$314.42 - $351.91 $5,345 - $5,982	-17 Reduced 15.74%	91 $32,000
Q1 2023 Apr 18, 2023	SELL	$283.23 - $323.1 $566 - $646	-2 Reduced 1.82%	108 $34,000
Q4 2022 Feb 08, 2023	SELL	$285.76 - $321.48 $220,035 - $247,539	-770 Reduced 87.5%	110 $31,000
Q3 2022 Oct 26, 2022	BUY	$273.83 - $305.53 $13,417 - $14,970	49 Added 5.9%	880 $255,000
Q2 2022 Jul 15, 2022	SELL	$234.96 - $292.55 $1.09 Million - $1.36 Million	-4,634 Reduced 84.79%	831 $234,000
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $31,663 - $37,318	-143 Reduced 2.55%	5,465 $1.43 Million
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $9,381 - $11,842	-53 Reduced 0.94%	5,608 $1.23 Million
Q3 2021 Oct 15, 2021	SELL	$181.39 - $202.99 $607,837 - $680,219	-3,351 Reduced 37.18%	5,661 $1.03 Million
Q2 2021 Jul 15, 2021	BUY	$187.49 - $221.1 $30,935 - $36,481	165 Added 1.87%	9,012 $1.82 Million
Q1 2021 Apr 15, 2021	BUY	$207.02 - $241.31 $496,019 - $578,178	2,396 Added 37.14%	8,847 $1.9 Million
Q4 2020 Jan 27, 2021	BUY	$207.01 - $276.09 $1.34 Million - $1.78 Million	6,451 New	6,451 $1.53 Million

Others Institutions Holding VRTX

# of Institutions

1,708

Shares Held

220M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolff Wiese Magana LLC with notifications on news.

Account

Wolff Wiese Magana LLC Vertex Pharmaceuticals Inc Transaction History